Verheul HMW - Search Results

1

Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma.

van Linde ME, Labots M, Brahm CG, Hovinga KE, De Witt Hamer PC, Honeywell RJ, de Goeij-de Haas R, Henneman AA, Knol JC, Peters GJ, Dekker H, Piersma SR, Pham TV, Vandertop WP, Jiménez CR, Verheul HMW. van Linde ME, et al. Among authors: verheul hmw. Clin Cancer Res. 2022 Apr 14;28(8):1595-1602. doi: 10.1158/1078-0432.CCR-21-1933. Clin Cancer Res. 2022. PMID: 35165100 Free PMC article.

2

Platelet: transporter of vascular endothelial growth factor.

Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM. Verheul HM, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2187-90. Clin Cancer Res. 1997. PMID: 9815613

3

Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas.

Verheul HM, Hoekman K, Lupu F, Broxterman HJ, van der Valk P, Kakkar AK, Pinedo HM. Verheul HM, et al. Clin Cancer Res. 2000 Jan;6(1):166-71. Clin Cancer Res. 2000. PMID: 10656446

4

Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.

van Hensbergen Y, Broxterman HJ, Hanemaaijer R, Jorna AS, van Lent NA, Verheul HM, Pinedo HM, Hoekman K. van Hensbergen Y, et al. Clin Cancer Res. 2002 Dec;8(12):3747-54. Clin Cancer Res. 2002. PMID: 12473585

5

Proteomics of the TRAP-induced platelet releasate.

Piersma SR, Broxterman HJ, Kapci M, de Haas RR, Hoekman K, Verheul HM, Jiménez CR. Piersma SR, et al. J Proteomics. 2009 Feb 15;72(1):91-109. doi: 10.1016/j.jprot.2008.10.009. Epub 2008 Nov 8. J Proteomics. 2009. PMID: 19049909

6

Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.

Vroling L, van der Veldt AA, de Haas RR, Haanen JB, Schuurhuis GJ, Kuik DJ, van Cruijsen H, Verheul HM, van den Eertwegh AJ, Hoekman K, Boven E, van Hinsbergh VW, Broxterman HJ. Vroling L, et al. Angiogenesis. 2009;12(1):69-79. doi: 10.1007/s10456-009-9133-9. Epub 2009 Feb 11. Angiogenesis. 2009. PMID: 19212818 Free article.

7

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib.

Broxterman HJ, Gotink KJ, Verheul HM. Broxterman HJ, et al. Drug Resist Updat. 2009 Aug-Oct;12(4-5):114-26. doi: 10.1016/j.drup.2009.07.001. Epub 2009 Aug 3. Drug Resist Updat. 2009. PMID: 19648052 Review.

8

Innovations and opportunities to improve conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancer.

Adema AD, Bijnsdorp IV, Sandvold ML, Verheul HM, Peters GJ. Adema AD, et al. Curr Med Chem. 2009;16(35):4632-43. doi: 10.2174/092986709789878229. Curr Med Chem. 2009. PMID: 19903145 Review.

9

Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.

Adema AD, Laan AC, Myhren F, Fichtner I, Verheul HM, Sandvold ML, Peters GJ. Adema AD, et al. Int J Oncol. 2010 Jan;36(1):285-94. Int J Oncol. 2010. PMID: 19956857

10

Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.

Albrethsen J, Knol JC, Piersma SR, Pham TV, de Wit M, Mongera S, Carvalho B, Verheul HM, Fijneman RJ, Meijer GA, Jimenez CR. Albrethsen J, et al. Mol Cell Proteomics. 2010 May;9(5):988-1005. doi: 10.1074/mcp.M900546-MCP200. Epub 2010 Jan 20. Mol Cell Proteomics. 2010. PMID: 20089989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page